Device Access has supported a wide range of international and European companies introducing high value medical technologies to the UK, effectively navigating the complex NHS reimbursement pathways through the creation and implementation of local and national market access strategies that demonstrate the technologies’ true value.
In 2017, Device Access became one of the first NICE approved facilitators for the MedTech Early Technical Assessment (META Tool®).
Device Access holds a data sharing agreement from NHS England, which provides data on all hospital admissions and outcomes on a monthly basis, allowing them to work with companies to further understand the impact technologies may have on current patient populations.
Device Access will provide support for market intelligence and market access research and training.